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AbstrACt
Objective To evaluate the effectiveness of a government-
regulated rehabilitation guideline compared with education 
and activation by general practitioners, and to a preferred-
provider insurance-based rehabilitation programme 
on self-reported global recovery from acute whiplash-
associated disorders (WAD) grade I–II.
Design Pragmatic randomised clinical trial with blinded 
outcome assessment.
setting Multidisciplinary rehabilitation clinics and general 
practitioners in Ontario, Canada.
Participants 340 participants with acute WAD grade I 
and II. Potential participants were sampled from a large 
automobile insurer when reporting a traffic injury.
Interventions Participants were randomised to receive 
one of three protocols: government-regulated rehabilitation 
guideline, education and activation by general practitioners 
or a preferred-provider insurance-based rehabilitation.
Primary and secondary outcome measures Our 
primary outcome was time to self-reported global 
recovery. Secondary outcomes included time on 
insurance benefits, neck pain intensity, whiplash-related 
disability, health-related quality of life and depressive 
symptomatology at 6 weeks and 3, 6, 9 and 12 months 
postinjury.
results The median time to self-reported global recovery 
was 59 days (95% CI 55 to 68) for the government-
regulated guideline group, 105 days (95% CI 61 to 126) for 
the preferred-provider group and 108 days (95% CI 93 to 
206) for the general practitioner group; the difference was 
not statistically significant (Χ2=3.96; 2 df: p=0.138). We 
found no clinically important differences between groups 
in secondary outcomes. Post hoc analysis suggests that 
the general practitioner (hazard rate ratio (HRR)=0.51, 
95% CI 0.34 to 0.77) and preferred-provider groups 
(HRR=0.67, 95% CI 0.46 to 0.96) had slower recovery 
than the government-regulated guideline group during 
the first 80 days postinjury. No major adverse events were 
reported.
Conclusions Time-to-recovery did not significantly differ 
across intervention groups. We found no differences 
between groups with regard to neck-specific outcomes, 
depression and health-related quality of life.
trial registration number NCT00546806.
IntrODuCtIOn   
Whiplash-associated disorder (WAD) is the 
most common traffic injury.1 WAD leads to 
a significant burden of disability and health-
care utilisation, and increases the risk of 
future health problems such as neck pain, 
headaches, low back pain, shoulder pain 
and sleep disturbances.1–10 Poor prognostic 
factors for WAD include history of neck pain 
strengths and limitations of this study
 ► We included a large sample of participants with 
acute whiplash-associated disorders.
 ► We used block randomisation to allocate partici-
pants to the treatment groups.
 ► We concealed treatment allocation.
 ► We used a patient-centred outcome (self-reported 
recovery) as the primary outcome, which was mea-
sured by a study interviewer who was blind to the 
treatment allocation.
 ► The main threats to the validity of the trial are loss 
to follow-up and the inability to blind participants to 
the received treatment.
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related to a traffic collision, older age, high initial pain 
levels and psychological factors (eg, poor expectation of 
recovery, depressive symptoms).11 12 
The clinical management of acute WAD is complex, 
and focuses on conservative interventions to manage 
symptoms and improve recovery.13–16 Evidence suggests 
that the type, intensity and timing of healthcare delivery 
may impact recovery, but the evidence is mixed.6 7 17–21 
A randomised trial reported that multidisciplinary indi-
vidualised treatments led to similar outcomes to usual 
care (from general practitioners, physiotherapists or 
chiropractors) in patients with acute WAD.21 Patients 
receiving high-intensity healthcare from general practi-
tioners, physiotherapists or chiropractors within the first 
month of injury experience slower recovery than patients 
who visited general practitioners once or twice.6 7 Simi-
larly, patients attending an early intensive multidisci-
plinary rehabilitation programme report slower recovery 
than those who received usual insured individual care.17 
However, a randomised trial reported that a physio-
therapy package (up to six sessions) provided slightly 
faster recovery than one additional physiotherapy advice 
session when added to emergency department consul-
tations.20 Overall, the body of evidence suggests that 
too much treatment too early after WAD may delay 
recovery,22 23 but further research is needed.
In 2008, the Bone and Joint Task Force on Neck Pain 
and its Associated Disorders (Neck Pain Task Force) 
recommended that the medical management of acute 
WAD without radiculopathy should include education, 
reassurance, pain management and rapid discharge.24 
Moreover, the Neck Pain Task Force recommended that 
rehabilitation providers use exercise, manual therapy 
and education to effectively manage acute WAD without 
radiculopathy.25 Recently, exorbitant healthcare costs and 
increasing disability rates have led governments (through 
regulations and legislations) and insurers (through 
preferred-provider networks) to implement guidelines for 
the treatment of WAD.1 9 17 26–30 Most guidelines empha-
sise education, reassurance, mobility, return-to-activity 
and exercise,29–31 but little evidence supports their effec-
tiveness.32 In Ontario, the provincial government intro-
duced guidelines (in the form of regulations) to ensure 
timely access to rehabilitation services, improve the utili-
sation of healthcare resources and establish consistent fee 
schedules for insurers and healthcare providers.29 30
Our primary objective was to evaluate the effective-
ness of a government-regulated rehabilitation guideline 
compared with education and activation (promoting self-
care and early return to normal activities of daily living) 
by general practitioners, and to a preferred-provider 
insurance-based rehabilitation programme on self-re-
ported global recovery from acute WAD grades I–II. Our 
secondary objectives aimed to determine which of the 
three interventions was more effective in reducing time 
on insurance benefits, neck pain intensity, whiplash-re-
lated disability, depressive symptoms and in improving 
health-related quality of life.
MethODs
Design and source population
We conducted a pragmatic randomised controlled trial 
(figures 1 and 2).33 We registered the trial at www. clin-
icaltrials. gov (NCT00546806). Participants were eligible 
for the study if they: 1) were ≥18 years; 2) resided or 
worked within the Greater Toronto Area, Mississauga, 
Burlington, Cambridge, Kitchener, Ajax or Pickering and 
3) were injured in a traffic collision and made an insur-
ance claim to AVIVA Canada between February 2008 and 
March 2011. AVIVA Canada is a national casualty and 
property insurer that held 9.5% of the automobile insur-
ance market in Ontario at the time of the study.34
Inclusion and exclusion criteria
Insurance adjusters (who manage insurance claims) 
informed claimants about the trial when making a claim. 
Claimants interested in the study were referred to a trial 
coordinator who confirmed eligibility and arranged for a 
clinical assessment. The trial coordinator assessed inclu-
sion and exclusion criteria using a standardised history, 
physical examination and diagnostic imaging if clinically 
indicated.
Individuals who met the following criteria were 
included: 1) insurance claim for physical injury and 
interviewed within 21 days of the traffic collision; 2) diag-
nosed with grade I–II WAD; 3) average neck pain since 
the collision ≥3/10 on the Numerical Rating Scale and 
4) completed interviews in English. Excluded were indi-
viduals with: 1) fracture/dislocation of the spine or major 
bone; 2) head trauma with loss of consciousness; 3) past 
whiplash or work-related neck injury within the year; 4) 
active systemic diseases (cancer, inflammatory arthritis, 
disorders of central nervous system); 5) previous neck 
surgery and 6) treated by physiotherapist or chiropractor 
for neck pain in the 3 months before the injury. All partic-
ipants provided written informed consent.
randomisation to treatment groups
Participants were randomly allocated to: 1) the govern-
ment-regulated guideline; 2) education and activation 
by a general practitioner or 3) the preferred-provider 
insurance-based rehabilitation programme. Participants 
from the same motor vehicle were allocated to the same 
treatment arm to minimise contamination and cross-over. 
A co-principal investigator independently performed 
central randomisation using NQuery Advisor 7.09.35 We 
used block randomisation with random block sizes of 3, 
6, 9 and 12 participants for each study site; treatment allo-
cation was concealed by providing trial coordinators with 
sequentially numbered sealed opaque envelopes for each 
study site.
Interventions
Participants received their interventions in person and 
individually within multidisciplinary rehabilitation (phys-
iotherapists, kinesiologists, occupational therapists and 
massage therapists) or general practitioner clinics in 
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Toronto, Mississauga, Cambridge, Ajax and Pickering, 
Ontario. All clinicians received training about the treat-
ment protocols. Clinicians provided care to one treatment 
arm only. As recommended by the Ontario Government 
regulatory body, all participants received an educational 
brochure entitled ‘Getting the Facts about Whiplash'.36
Government-regulated guideline
The goal of the government-regulated guideline was to 
ensure timely access to rehabilitation services, improve 
healthcare utilisation and establish consistent fee sched-
ules for insurers and healthcare providers.29 30 The treat-
ment was multimodal, tailored to participants’ needs and 
Figure 1 Consolidated Standards of Reporting Trials diagram.
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could include: 1) education, reassurance, home stretching 
exercises and encouragement to resume normal activ-
ities; 2) clinic-based exercises and functional activities; 
3) manipulation or mobilisation; 4) pain management 
modalities (including massage therapy) and 5) coping 
skills education (online supplementary appendix 1).36 
The physiotherapists determined the duration, frequency 
and number of visits, which was limited to 10 during the 
first 3 weeks of care, and to 9 after 3 weeks, for the period 
extending from weeks 4 to 6.
Participants with functional limitations were eligible 
for an assessment by an occupational therapist, which 
could lead to: 1) recommendation to use aids or devices; 
2) minor modifications in the work, home or school 
Figure 2 Consolidated Standards of Reporting Trials diagram (continued).
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environment; 3) instructions on adaptive strategies or 
alternative approaches to fulfil functional tasks and 4) 
specific functional activities.
Participants who reported significant improvement 
in the first 6 weeks of care, but had not reached satis-
factory clinical recovery, were eligible to receive up to 
four additional treatment sessions over a 2-week period. 
The physiotherapist re-evaluated participants who had 
not recovered by 9 weeks and developed a new plan of 
management that was submitted to the insurer.
Preferred-provider insurance-based rehabilitation programme
The rehabilitation programme was designed by AVIVA 
Canada to initiate care within a preferred-provider 
network in a timely and efficient manner by removing 
administrative barriers (claim paper work) associated 
with the claim initiation process. The insurer hypothe-
sised that providing quick access to care and reducing the 
administrative burden on claimants would prevent adver-
sarial relationships and facilitate recovery.
The clinical interventions included in the preferred-pro-
vider insurance-based rehabilitation programme were 
similar to the government-regulated guideline (online 
supplementary appendix 1). A maximum of nine treat-
ments (including massage therapy) were allowed during 
first 3 weeks postcollision with an additional eight sessions 
(including massage therapy) during the subsequent 
3 weeks if necessary. The physiotherapist determined 
the duration, interventions and frequency of visits, and 
recommended an in-home or job-site functional assess-
ment if indicated. The primary differences between the 
government-regulated guideline and the preferred-pro-
vider insurance-based rehabilitation programme were: 1) 
a reduction of the administrative burden for the claimant 
and 2) the possibility of participants who did not recover 
during the first 6 weeks of care to be referred (at the 
discretion of the physiotherapist) for a multidisciplinary 
evaluation at one of the study clinics.
education and activation by general practitioner
The education and activation intervention programme 
promoted self-care and early return to normal activi-
ties (online supplementary appendix 1). Study general 
practitioners were asked to see participants once unless 
follow-up was clinically indicated. During the initial 
consultation, the general practitioner: 1) reassured the 
participant about the favourable prognosis of WAD; 2) 
encouraged the participant to resume normal activities; 
3) recommended home stretching exercises for the area 
of complaint (neck, shoulder, back and hip) and 4) if 
indicated, prescribed pain relief modalities or medica-
tion (heat/ice, acetaminophen or non-steroidal anti-in-
flammatory drug). Participants were informed to contact 
the general practitioner should their complaint persist 
or worsen. If follow-up visits were necessary, the general 
practitioner re-assessed the participant and the education 
and activation intervention was repeated. The maximum 
number of visits during the first 6 weeks was two for this 
treatment arm. Participants who did not recover during 
the first 6 weeks of care could be referred (at the discre-
tion of the general practitioner) for a multidisciplinary 
evaluation at one of the study clinics.
Multidisciplinary evaluation
The multidisciplinary evaluation (by a physiotherapist 
and kinesiologist) involved a functional evaluation and 
recommendation for further physiotherapy care or an 
interdisciplinary rehabilitation programme to over-
come psychosocial barriers to return to function, and 
facilitate physical and functional restoration if deemed 
appropriate. This programme included up to 5 weeks of 
daily intervention. The interdisciplinary team (involving 
a physiotherapist, general practitioner, occupational 
therapist, psychologist and kinesiologist) determined 
the frequency, duration and type of care, which could 
include: 1) education and reassurance; 2) goal setting and 
advice on self-management; 3) psychological counselling 
and stress management; 4) relaxation therapy, psycho-
therapy and family counselling; 5) cognitive behavioural 
therapy; 6) instruction on pain management techniques 
and 7) strength, endurance, flexibility or cardiovascular 
exercises.
Data collection and follow-up
Using a standardised questionnaire, a trial coordinator 
collected baseline data prior to randomisation (online 
supplementary appendix 2). Participants were followed 
at 6 weeks, and 3, 6, 9 and 12 months postinjury. Research 
assistants blind to treatment allocation collected all 
follow-up data primarily via telephone, or in-person at 
the treating clinic, if requested. During the first year of 
the trial, participant feedback and the lower participation 
than expected suggested that answering the question-
naire was too burdensome. Therefore, we offered partic-
ipants who did not wish to complete the full follow-up 
questionnaire to answer either: 1) two outcome questions 
(self-reported global recovery and neck pain intensity) 
and a question used for the cost-effectiveness analysis 
(rating general health state on a Numerical Rating Scale) 
(data not reported in this paper) or 2) an abbreviated 
version of the full follow-up questionnaire (online supple-
mentary appendix 3).
OutCOMes
Primary outcome
Time to self-reported global recovery: self-reported global 
recovery was measured with the self-reported global 
recovery question, which is valid and reliable in patients 
with WAD.17 37–39 This ordinal transition scale has previ-
ously been used in randomised trials and cohort studies of 
neck pain.17 40 41 In patients with WAD, we have previously 
reported that perceived recovery is consistently associated 
with less neck pain, better physical functioning and fewer 
depressive symptoms.17 Participants were asked: "How 
well do you feel you are recovering from your injuries?” 
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and had the following choices: completely better; much 
improved; slightly improved; no change; slightly worse; 
much worse and worse than ever. Time to self-reported 
global recovery was measured as the number of days 
between the date of injury and the first follow-up date 
at which a participant reported being ‘completely recov-
ered’ or ‘much improved’.
secondary outcomes
Neck pain intensity in the past 24 hours: the 11-point Numer-
ical Rating Scale is a global measure of pain intensity 
anchored by two extremes of pain intensity ranging from 
0 (‘no pain’) to 10 (‘pain as bad as it could be’). It has 
good short-term test-retest reliability, good construct 
validity and can distinguish levels of pain in subjects with 
chronic pain.42 43
Whiplash disability: the Whiplash Disability Question-
naire consists of 13 items that measure the effect of whip-
lash on pain, personal care, work/home/study duties, 
driving/public transportation, sleep, tiredness/fatigue, 
social activity, sporting activity, non-sporting leisure 
activity, depression/sadness, anxiety, anger and concen-
tration. Each item is scored from 0 to 10, with a total 
sum of 130, with higher global scores indicating more 
disability.26 It has adequate reliability, validity and respon-
siveness.26 44–47
Health-related quality of life: the 36-item Short Form 
Survey (SF-36) includes eight individual scales (physical 
functioning, role physical, bodily pain, general health, 
vitality, social functioning, role emotional and mental 
health) used to compute the physical component and 
mental component scores in the past 4 weeks. It is valid, 
reliable and responsive in participants with musculoskel-
etal conditions.48–51
Depressive symptomatology: the Centre for Epidemiolog-
ical Studies-Depression Scale (CES-D) is a widely used 
20-item self-report scale designed to measure current 
level of depressive symptomatology.52 53 The CES-D is 
scored from 0 to 60 with higher scores indicating greater 
depressive symptomatology.54 55 It has good test-retest reli-
ability, and good factorial and discriminant validity.54–59
Time on insurance benefit: we measured number of 
days between date of injury and date of insurance claim 
closure. Claim closure corresponds to the end of treat-
ment, attainment of maximal medical improvement, 
termination of income replacement benefits or date 
of payment of the last outstanding bill incurred by the 
claimant (eg, device purchased). AVIVA Canada provided 
the claim closure dates. Time to claim closure is a valid 
marker of time to health recovery (ie, lower levels of neck 
pain, better physical functioning and no depression).60 61
The secondary outcomes of 1) satisfaction with care and 
satisfaction with treatment and 2) recurrence described 
in our protocol are not reported in this manuscript. The 
full follow-up questionnaire was deemed too burdensome 
to participants and these outcomes were subsequently 
eliminated.
Co-interventions
We measured co-interventions by asking participants 
to self-report the type of healthcare provider consulted 
beyond those involved in delivering trial interventions 
(ie, chiropractor, physiotherapist, massage therapist, 
medical specialist, psychologist or counsellor and other 
healthcare providers (acupuncturist, naturopath, homeo-
path, Chinese medicine practitioner)).
Adverse events
We measured adverse events at each follow-up interview, 
defined as an unintended sign or symptom of the inter-
vention (eg, neck pain, radiating pain in arms, feeling 
tired, headache, depression or other physical discomfort).
sample size
We aimed to detect a 20% difference in rate of self-re-
ported global recovery at 1 year using a log rank test with 
80% power and a two-tail significance level of 0.05.62 In 
our trial protocol, we specified 90% power.33 We revised 
the power of the trial from 90% to 80% because of the 
challenges associated with recruitment. Using these 
parameters, we needed 86 participants per group. 
Assuming a 30% loss to follow-up per arm, we needed 336 
participants (ie, 112 per arm).
statistical analysis
We conducted analyses according to the intention-to-
treat principle. We described participant demographic 
and clinical characteristics at baseline (eg, mean, 95% CI, 
median, range) and conducted inference testing as 
appropriate (eg, t-test, Χ2 test, Kruskal-Wallis test).
Primary outcome
We used Kaplan-Meier estimates to derive median time 
to self-reported global recovery and 95% CI. Using the 
government-regulated group as the reference interven-
tion, we quantified the relative effectiveness of inter-
ventions by computing the hazard rate ratio (HRR) and 
95% CI using Cox proportional hazards models.63–67 We 
computed the Wald Χ2 statistic to determine whether the 
difference between groups was significant (p<0.05). We 
used two methods to test the proportionality assumption 
of our model. First, we tested the significance of an inter-
action term between the intervention groups and log of 
time. Second, we fitted piecewise proportional hazards 
models.
Baseline characteristics that differed between groups 
and changed either of the regression coefficients by 10% 
or more were controlled for in the primary analysis.68 
Observations were censored at 3 weeks for participants 
who dropped out prior to the first follow-up interview, or 
on the date of their last completed follow-up interview for 
those who provided follow-up data.
secondary outcomes
We computed mean differences (and 95% CI) within and 
between groups from baseline to each follow-up point. We 
used standardised cut-off values to determine if clinically 
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important differences were reached at each time point: 
1) two points on the 11-point Numeric Rating Scale37; 2) 
21.4 points on the Whiplash Disability Questionnaire (ie, 
the minimal detectable change)46 and 3) 7.7 points for 
the SF-36 Physical Component Score.69 The minimal clin-
ically important differences for CES-D and SF-36 Mental 
Component Score have not been established in this 
population; therefore, we considered a 10% change from 
baseline to be clinically important. We used Generalised 
Estimating Equations models to account for effects due 
to study arm, different follow-up times and the interac-
tion between study arm and follow-up times. We used an 
exchangeable correlation structure to account for with-
in-subject correlation over time. Finally, we used Kaplan-
Meier estimates to derive median time to claim closure 
and Cox proportional hazards models to analyse time on 
insurance benefits according to the methods described 
above.63–67
Patient and public involvement
Patients were not involved in the development of the 
research question, study design, choice of outcome 
measures or recruitment for the study. Participants did 
not assess the burden of the interventions. We will use 
social media and our university website to inform the 
public about the results of the study.
results
study sample
We received 1348 referrals and 422 individuals from 
336 automobile collisions were clinically assessed for 
inclusion in the trial. Of these, 340 participants were 
randomised: 113 cars (115 participants) to the govern-
ment-regulated guideline, 113 cars (113 participants) to 
the preferred-provider group and 110 cars (112 partic-
ipants) to education and activation (figures 1 and 2; 
online supplementary appendix 4). Overall, 86.7% of 
participants received the allocated intervention (at least 
one session): 83.5% for the government-regulated guide-
line, 84.1% for preferred-provider rehabilitation and 
92.9% for the education and activation group.
sample characteristics
Baseline characteristics were well balanced between 
groups (table 1). The mean physical component score 
of the SF-36 and active coping score were higher in the 
government-regulated guideline group, but these differ-
ences were small and therefore not clinically mean-
ingful. The education and activation group included a 
smaller proportion of employed participants and a larger 
proportion of participants with hypertension. Finally, 
the preferred-provider group included a smaller propor-
tion of participants who expected to get better soon. 
Among these baseline characteristics, only expectation of 
recovery changed the regression coefficients by at least 
10% (online supplementary appendix 5). Therefore, 
expectation of recovery was adjusted for in the primary 
analysis.
healthcare services
The mean number of visits during the first 3 weeks of care 
was 3.8 (SD 2.3) for the government-regulated guideline 
group and 2.7 (SD 1.9) for the preferred-provider reha-
bilitation group. Similarly, it was 2.8 visits (SD 2.4) for 
government-regulated guideline and 2.7 (SD 2.5) for the 
preferred-provider rehabilitation during the subsequent 
3 weeks. The education and activation group had a mean 
of 1.5 visits to general practitioners (SD 0.8) during the 
first 6 weeks of care.
A total of 48 participants from the preferred-provider 
and education and activations groups were referred 
for multidisciplinary evaluation. Twenty-two of the 28 
(24.8%) referred participants from the preferred-pro-
vider group attended their multidisciplinary evaluation. 
In the education and activation group, 20 participants 
(17.9%) were referred and 19 attended.
Compared with the government-regulated guideline 
group, a higher proportion of participants in the other two 
groups received treatment outside of the protocol (online 
supplementary appendix 6). Specifically, they used more 
massage therapy, physiotherapy and chiropractic. Some 
participants visited their own general practitioner within 
the first 6 weeks of care (27.5% for government-regulated 
guideline group, 43.8% for the preferred-provider group, 
34.8% for education and activation group).
Follow-up
Follow-up rates at 12 months were 80.9% for the 
government-regulated guideline group; 84.1% for the 
preferred-provider group and 71.4% for those receiving 
education and activation. The follow-up rate for the 
primary outcome was 74.1% at 6 weeks, 65.3% at 3 
months, 61.8% at 6 months, 54.4% at 9 months and 78.8% 
at 1 year. Following the 9 month follow-up, we adapted 
our follow-up strategy to minimise selection bias due to 
increasing attrition. Trial coordinators called participants 
who could not be reached by the research assistant and 
invited to talk to the research assistant to complete the 
final interview. Overall, 91.1% of participants provided 
follow-up data and were included in the analysis (figures 1 
and 2). Not providing follow-up data was associated 
with consulting a lawyer, direction of impact, expecta-
tion of recovery, self-reported cardiovascular problems, 
self-reported gastrointestinal problems and mental and 
emotional problems prior to the collision (online supple-
mentary appendix 7).
self-reported global recovery
The median time to recovery was 59 days (95% CI 55 to 68) 
for the government-regulated group, 105 days (95% CI 61 
to 126) for the preferred-provider rehabilitation group 
and 108 days (95% CI 93 to 206) for the education and 
activation group (figure 3). The time to recovery between 
groups was not significant (Χ2=3.96; 2 df: p=0.138). 
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Table 1 Baseline characteristics
Variable
Government-
regulated guideline 
n=115
Preferred-provider 
insurance-based 
rehabilitation n=113
General practitioner 
education and 
activation n=112
Sociodemographic
  Female, N (%) 81 (70.4) 70 (61.9) 78 (69.6)
  Age, mean (SD) 38.9 (11.7) 39.5 (12.1) 43.2 (15.2)
  Marital status: N (%)
   Married/common law 60 (52.2) 62 (54.9) 62 (55.4)
   Single/never married 33 (28.7) 35 (31.0) 30 (26.8)
   Separated/divorced/widowed 22 (19.1) 16 (14.2) 20 (17.9)
  Educational level: N (%)
   High school or less 23 (20.0) 21 (18.6) 26 (23.2)
   Some postsecondary/technical school 52 (45.2) 57 (50.4) 46 (41.1)
   University graduate 40 (34.8) 35 (31.0) 40 (35.7)
  Income level: N (%)
   ≤US$49 000 57 (50.0) 53 (46.8) 58 (51.9)
   US$50 000–US$79 999 39 (33.9) 32 (27.9) 31 (27.8)
   ≥US$80 000 19 (16.1) 28 (25.2) 23 (20.4)
  Employed at the time of the collision, N (%) 98 (85.2) 101 (89.4) 87 (77.7) 
   Dependents, N (%), n=338
    None 51 (44.4) 51 (45.1) 62 (56.4)
    2–3 46 (40.0) 48 (42.5) 32 (29.1)
    ≥3 18 (15.7) 14 (12.4) 16 (14.6)
  Legal/insurance variables at the baseline interview
  Arguing with insurer, N (%) 6 (5.3) 9 (8.0) 6 (5.4)
  Lawyer involvement, N (%) 4 (3.5) 8 (7.1) 8 (7.1)
Collision
  Days since collision, median (IQR) 6.0 (5.0) 5.0 (5.0) 6.0 (6.0)
  Car stopped, N (%) 56 (49.1) 49 (42.5) 49 (43.6)
  Position in car, N (%), n=339*
   Driver 103 (90.4) 106 (93.8) 99 (88.4)
   Front seat passenger 7 (6.1) 5 (4.4) 9 (8.0)
   Back seat passenger 3 (2.6) 1 (0.9) 3 (2.7)
   Cyclist 1 (0.9) 1 (0.9) 1 (0.9)
  Direction of impact, N (%)
   Front 18 (15.8) 31 (27.4) 26 (23.2)
   Rear 56 (49.1) 51 (45.1) 53 (47.3)
   Driver side 11 (9.6) 16 (14.2) 12 (10.7)
   Passenger side 16 (14.0) 6 (5.3) 16 (14.3)
   Other 13 (11.4) 9 (8.0) 5 (4.5)
  Car drivable postcollision, N (%) 54 (47.3) 47 (41.3) 51 (45.9)
  Seat belt fastened, N (%), n=334* 111 (99.1) 110 (99.1) 109 (98.2)
  Head rest, N (%), n=330* 110 (99.1) 111 (99.1) 104 (95.4)
  Number of occupants in vehicle, N (%), n=337
   1 73 (64.0) 86 (76.8) 83 (74.8)
   2–3 37 (32.5) 21 (18.8) 26 (23.4)
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Variable
Government-
regulated guideline 
n=115
Preferred-provider 
insurance-based 
rehabilitation n=113
General practitioner 
education and 
activation n=112
   ≥4 4 (3.5) 5 (4.5) 2 (1.8)
  Previous injury claim in past 2 years, N (%), n=340 0 0 2 (1.8)
  Number of personal claims in past 2 years, N (%), 
n=340*
   None 110 (95.7) 105 (92.9) 105 (93.8) 
   1 4 (3.5) 8 (7.1) 7 (6.3) 
   ≥2 1 (0.9) 0 (0.0) 0 (0.0) 
  Chiropractic care in past 3 months, N (%), n=340 4 (3.5) 8 (7.1) 5 (4.5)
  Physical therapy in past 3 months, N (%), n=340* 5 (4.3) 3 (2.7) 6 (5.4)
Postinjury diagnosis and symptoms
  WAD grade: N (%)
   I 41 (35.7) 34 (30.1) 26 (23.2)
   II 73 (64.3) 79 (69.9) 86 (76.8)
  Body part injured: N (%)
   Neck 115 (100.0) 113 (100.0) 112 (100.0)
   Face 12 (10.4) 13 (11.5) 13 (11.6)
   Low back 73 (63.5) 74 (65.2) 74 (66.1)
   Arm(s) 48 (41.7) 47 (41.6) 52 (46.4)
   Leg(s) 31 (27.0) 41 (36.3) 38 (33.9)
   Foot/feet 9 (7.8) 14 (12.4) 19 (17.0)
   Abdomen/chest/groin 33 (28.7) 39 (34.5) 43 (38.4)
   Shoulder(s) 92 (80.0) 95 (84.1) 92 (82.1)
   Mid-back 88 (76.5) 81 (71.7) 78 (69.6)
   Head 57 (49.6) 53 (46.9) 61 (54.5)
   Hand(s) 29 (25.2) 27 (23.9) 35 (31.2)
  Average pain in past 24 hours†
   Neck: mean (SD) 5.6 (2.1) 5.7 (2.0) 5.9 (2.1)
   Shoulder: mean (SD) 4.7 (2.7) 4.8 (2.8) 5.0 (2.9)
   Low back: mean (SD) 4.1 (3.2) 4.1 (3.4) 4.3 (3.5)
   Headache: mean (SD) 3.7 (3.3) 3.5 (3.3) 4.1 (3.4)
   Arm: mean (SD) 1.9 (2.7) 2.4 (2.9) 2.4 (3.1)
   Mid-back: mean (SD) 4.2 (3.0) 4.2 (3.0) 4.3 (3.4)
   Hand: median (IQR) 0.0 (0.0) 0.0 (1.0) 0.0 (3.0)
   Face: median (IQR) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
   Leg: median (IQR) 0.0 (2.0) 0.0 (4.0) 0.0 (3.0)
   Foot: median (IQR) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
   Abdomen/chest/groin: median (IQR) 0.0 (1.0) 0.0 (2.0) 0.0 (4.0)
  Loss of consciousness, N (%), n=326* 0 (0.0) 1 (0.9) 0 (0.0)
  Loss of memory, N (%), n=324* 8 (7.2) 12 (11.4) 10 (9.3)
  Disorientation/confusion postcollision, N (%), n=330* 38 (34.6) 44 (39.6) 51 (46.8)
Postinjury healthcare 
  Attended hospital or emergency care, N (%), n=340* 30 (26.1) 29 (25.7) 35 (31.2)
  Received healthcare since collision, N (%), n=340 67 (58.3) 61 (54.0) 71 (63.4)
Preinjury comorbidities*
Table 1 Continued 
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Variable
Government-
regulated guideline 
n=115
Preferred-provider 
insurance-based 
rehabilitation n=113
General practitioner 
education and 
activation n=112
  Number of comorbidities‡: N (%)
   None 13 (11.3) 8 (7.1) 10 (8.9)
   1–2 48 (41.7) 47 (41.6) 54 (48.2)
   >3 54 (47.0) 58 (51.3) 48 (42.9)
  Muscle, bone, joint problems: N (%), n=340*
   Does not have the condition 65 (56.5) 63 (55.7) 66 (58.9)
   Mild effect or not at all 42 (36.5) 39 (34.5) 37 (33.0)
   Moderate to severe effect 8 (7.0) 11 (9.7) 9 (8.0)
  Allergies: N (%), n=340
   Does not have the condition 57 (49.6) 59 (52.2) 64 (57.1)
   Mild effect or not at all 50 (43.5) 48 (42.5) 44 (39.3)
   Moderate to severe effect 8 (7.0) 6 (5.3) 4 (3.6)
  Breathing problems: N (%), n=340
   Does not have the condition 81 (70.4) 81 (71.7) 86 (76.8)
   Mild effect or not at all 22 (19.1) 25 (22.1) 22 (19.6)
   Moderate to severe effect 12 (10.4) 7 (6.1) 4 (3.6)
  Hypertension: N (%), n=340
   Does not have the condition 105 (91.3) 100 (88.5) 90 (80.4)
   Mild effect or not at all 10 (8.7) 9 (8.0) 20 (17.9)
   Moderate to severe effect 0 (0.0) 4 (3.5) 2 (1.8)
  Cardiovascular problems: N (%), n=340
   Does not have the condition 100 (87.0) 100 (88.5) 100 (89.3)
   Mild effect or not at all 13 (11.3) 8 (7.1) 10 (8.9)
   Moderate to severe effect 2 (1.7) 5 (4.4) 2 (1.7)
  Gastrointestinal problems: N (%), n=340
   Does not have the condition 97 (84.3) 94 (83.2) 97 (86.6)
   Mild effect or not at all 11 (9.6) 11 (9.7) 9 (8.0)
   Moderate to severe effect 7 (6.1) 8 (7.1) 6 (5.4)
  Diabetes: N (%), n=340
   Does not have the condition 112 (97.4) 110 (97.3) 107 (95.5)
   Mild effect or not at all 3 (2.6) 2 (1.8) 5 (4.5)
   Moderate to severe effect 0 (0.0) 0 (0.0) 0 (0.0)
  Kidney/genitourinary problems: N (%), n=340
   Does not have the condition 98 (85.2) 95 (84.1) 100 (89.3)
   Mild effect or not at all 11 (9.6) 11 (9.7) 9 (8.0)
   Moderate to severe effect 6 (5.2) 7 (6.2) 3 (2.7)
  Headache: N (%), n=340
   Does not have the condition 56 (48.7) 51 (45.1) 68 (60.7)
   Mild effect or not at all 48 (41.7) 49 (43.4) 36 (32.1)
   Moderate to severe effect 11 (9.6) 13 (11.5) 8 (7.1)
  Mental/emotional problems: N (%), n=340
   Does not have the condition 85 (73.9) 86 (76.1) 87 (77.7)
   Mild effect or not at all 21 (18.3) 14 (12.4) 13 (11.6)
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Compared with the government-regulated group, rate 
of recovery was 13% slower in the preferred-provider 
rehabilitation group (adjusted HRR=0.87; 95% CI 0.64 
to 1.18) and 28% slower in the education and activation 
group (adjusted HRR=0.72; 95% CI 0.53 to 1.00).
Proportionality assumptions of the model
Our analysis showed that the interaction between treat-
ment groups and the log of time was not statistically 
significant (time×general practitioner group, p=0.08; 
time×preferred-provider group, p=0.25). However, on 
observing the shape of the Kaplan-Meier curves, two 
possible inflection times were identified: the first one at 
60 days and the second one at 80 days. Therefore, we built 
two post hoc piecewise proportional hazards models. The 
first model (split at 60 days) did not yield any substan-
tial improvement compared with the original Cox model 
(likelihood ratio statistic=3.74; 2 df: p=0.15). However, 
the second model (split at 80 days) showed substantial 
improvement compared with the original Cox model 
(likelihood ratio statistic=7.76; 2 df: p=0.02). Compared 
with the government-regulated guideline group, the 
general practitioner (delivering education and activa-
tion) and preferred-provider groups had slower rates of 
recovery during the first 80 days (HRR=0.51, 95% CI 0.34 
to 0.77 and HRR=0.67, 95% CI 0.46 to 0.96, respectively), 
but not beyond that (HRR=1.26, 95% CI 0.74 to 2.16 and 
HRR=1.33, 95% CI 0.78 to 2.27, respectively).
secondary outcomes
Neck pain intensity, whiplash-related disability, depres-
sive symptomatology and health-related quality of life 
improved in all groups during follow-up (table 2), but 
there were no significant differences between groups 
(p>0.05; table 3).
The median time on insurance benefits was similar 
between groups: 300 days (95% CI 256 to 373) for the 
government-regulated guideline group; 283 days (95% CI 
221 to 393) for preferred-provider rehabilitation and 321 
days (95% CI 250 to 417) for the education and activation 
Variable
Government-
regulated guideline 
n=115
Preferred-provider 
insurance-based 
rehabilitation n=113
General practitioner 
education and 
activation n=112
   Moderate to severe effect 9 (7.8) 13 (11.5) 12 (10.7)
  Cancer: N (%), n=340
   Does not have the condition 110 (95.7) 110 (97.3) 106 (94.6)
   Mild effect or not at all 3 (2.6) 3 (2.7) 5 (4.5)
   Moderate to severe effect 2 (1.7) 0 (0.0) 1 (0.9)
  Expectation of recovery, N (%), n=340
   Get better soon 69 (60.0) 43 (38.1) 53 (47.3)
   Get better slowly 25 (21.7) 45 (39.8) 31 (27.7)
   Never get better/do not know 21 (18.3) 25 (22.1) 28 (25.0)
  Health transition statement, N (%), n=340
   Excellent/very good 11 (9.6) 9 (8.0) 10 (8.9)
   Good 24 (20.9) 18 (15.9) 26 (23.2)
   Fair/poor 80 (69.6) 86 (76.1) 76 (67.9)
SF-36 scores
  Physical CS (SF-36), mean (SD) 40.2 (9.0) 38.2 (9.4) 36.8 (9.4)
  Mental CS (SF-36), mean (SD) 45.9 (12.7) 45.2 (14.6) 45.1 (13.1)
  CES-D, mean (SD) 13.9 (11.9) 15.9 (13.6) 16.5 (12.2)
Vanderbilt Pain Management Inventory scores
  Active coping, mean (SD) 15.7 (3.5) 15.2 (3.2) 14.2 (4.3)
  Passive coping, mean (SD) 14.3 (3.9) 15.2 (3.9) 15.1 (4.5)
Whiplash disability
  WDQ, mean (SD) 49.6 (28.6) 57.8 (29.9) 57.1 (28.9)
*Fisher’s exact test was used when expected cell counts was less than five in 25% or more of the cells.
†Kruskal-Wallis test was conducted where median (ranges) were reported.
‡Comorbidities include allergies, arthritis, blood problems, breathing problems, cancer, diabetes, digestive disorders, genitourinary problems, 
heart/circulation problems and headaches.
CES-D, Centre for Epidemiological Studies-Depression Scale; CS, component score; SF-36,  36-item Short Form Survey; WAD, whiplash-
associated disorders; WDQ, Whiplash Disability Questionnaire.
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group (online supplementary appendix 8). Compared 
with the government-regulated guideline group, there 
were no differences in the rate of claim closure between 
groups (preferred-provider rehabilitation group: 
HRR=1.01, 95% CI 0.71 to 1.37; education and activation 
group: HRR=0.91, 95% CI 0.65 to 1.30).
Adverse events
There were no adverse events related to the study inter-
ventions. However, nine participants reported the 
following conditions during the trial: 1) government-reg-
ulated guideline group: suicidal ideation (n=1), otoscle-
rosis (n=1), transient vertigo (n=1), one urinary retention 
and foot drop (n=1); 2) preferred-provider rehabilitation 
group: detached retina (n=1), arthroscopic knee surgery 
(n=1) and lump in neck (n=1) and 3) education and 
activation group: hip fracture (n=1) and ankle fracture 
(n=1).
DIsCussIOn
We conducted a pragmatic randomised controlled trial 
of the effectiveness of a government-regulated rehabili-
tation guideline for the management of acute WAD. We 
found that the government-regulated guideline was not 
associated with a statistically significant improvement 
in recovery compared with general practitioner educa-
tion and activation or preferred-provider rehabilitation 
in patients with acute WAD grade I–II. Similarly, we did 
not find differences in secondary outcomes. However, 
our post hoc analysis suggests that the government-reg-
ulated rehabilitation guideline may have a short-term 
limited effect (first 80 days) on self-reported recovery. 
The reasons for this temporary effect are not known, but 
cannot be attributed to differential follow-up times. The 
median follow-up times (IQR) at the 6-week and 3-month 
follows-up were, respectively: 43 days (IQR 42–49) and 
95 days (IQR 92–104) for the education and activation 
group; 44 days (IQR 41–51) and 96 days (IQR 91–107) for 
the preferred-provider group and 45 days (IQR 42–50) 
and 95 days (IQR 91–105) for the government-regulated 
guideline. While the role of chance cannot be ruled out, 
it is possible that additional care received by 41 partic-
ipants in the preferred-provider and activation and 
education groups may have impacted perceived recovery. 
The median time for a multidisciplinary examination to 
occur was 55.5 days (IQR 47–70) for the preferred-pro-
vider group (n=22) and 55 days (IQR 35–85) days for the 
education and activation group (n=19). The median time 
to begin interdisciplinary rehabilitation was 64 days (IQR 
57–782) and 65 days (IQR 49–157) from recruitment 
for the preferred provider and education and activation 
groups, respectively.
Our findings are partly consistent with the results of a 
previous randomised trial. Jull et al reported no differ-
ences in neck pain and disability (measured on Neck 
Disability Index) between participants allocated to 
multidisciplinary individualised treatments compared 
with usual care.21 Similarly, we found no differences 
in secondary outcomes (including neck disability) 
between treatment arms. However, we found that 
government-regulated guideline may promote time-lim-
ited short-term faster self-perceived global recovery. 
Although these results may appear paradoxical, they 
are not contradictory; recovery for musculoskeletal 
injuries is not necessarily synonymous with resolution of 
symptoms; patients report recovery when they are able 
to adjust to their condition, or adapt to living with their 
condition.70
Figure 3 Intention-to-treat analysis for time to self-reported global recovery (reporting ‘completely recovered’ or ‘much 
improved’). GP, general practitioner.
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Our findings are significant because they suggest that 
guidelines developed and regulated by governments may 
improve self-perceived recovery from WAD. Although 
guidelines are developed to reduce the gap between 
research and clinical care, their use and adherence by 
clinicians is poor.71 72 Our study suggests that the imple-
mentation of guidelines by government agencies could 
improve early recovery from traffic injuries.73 This finding 
has implications beyond North America because WAD is 
associated with a high burden of disability throughout the 
world.11 74 75
Our trial provides important clinical information 
regarding the effective dose of care necessary to promote 
recovery in patients with acute WAD. Participants 
randomised to the government-regulated guideline 
received an average of 6.5 treatments during the first 
6 weeks of care. This finding agrees with the results of 
a recent systematic review, which reported that effective 
Table 2 Within-group differences from baseline to follow-up for secondary outcomes*
Outcome
Government-regulated 
guideline
Mean difference 
(95% CI)
Preferred-provider 
insurance-based 
rehabilitation
Mean difference (95% CI)
General practitioner 
education and activation
Mean difference 
(95% CI)
Neck pain intensity
  6 weeks (n=85; 79; 72)† 2.7 (2.1 to 3.3) 2.2 (1.6 to 2.8) 2.4 (1.7 to 3.0)
  3 months (n=76; 70; 64)† 3.5 (2.9 to 4.0) 3.3 (2.7 to 3.9) 3.3 (2.6 to 3.9)
  6 months (n=62; 66; 63)† 3.4 (2.8 to 4.1) 3.2 (2.5 to 3.8) 3.6 (3.0 to 4.3)
  9 months (n=60; 45; 49)† 3.7 (3.1 to 4.3) 4.0 (3.4 to 4.5) 3.8 (3.1 to 4.4)
  12 months (n=86; 81; 70)† 3.6 (3.0 to 4.2) 3.2 (2.6 to 3.8) 3.6 (2.9 to 4.2)
Whiplash disability
  6 weeks (n=80; 73; 68)† 17.7 (9.2 to 26.1) 19.9 (11.7 to 28.1) 20.9 (13.0 to 28.9)
  3 months (n=69; 62; 61)† 25.9 (18.2 to 33.6) 30.6 (22.9 to 38.3) 28.3 (20.9 to 35.7)
  6 months (n=57; 61; 56)† 22.3 (13.9 to 30.7) 29.9 (21.9 to 37.8) 35.6 (28.2 to 43.0)
  9 months (n=60; 37; 44)† 29.4 (21.8 to 36.9) 41.7 (34.8 to 48.6) 36.7 (29.8 to 43.6)
  12 months (n=50; 43; 37)† 29.3 (21.4 to 37.2) 39.8 (32.3 to 47.3) 37.0 (29.7 to 44.2)
Depressive symptomatology
  6 weeks (n=78; 71; 65)† 3.0 (−0.3 to 6.3) 2.0 (−1.5 to 5.4) 4.8 (1.5 to 8.0)
  3 months (n=69; 61; 59)† 4.2 (0.8 to 7.6) 6.8 (3.6 to 9.9) 5.7 (2.6 to 8.7)
  6 months (n=55; 59; 56)† 3.1 (−0.5 to 6.7) 5.6 (2.1 to 9.0) 7.1 (4.0 to 10.2)
  9 months (n=58; 37; 43)† 5.3 (2.1 to 8.4) 7.5 (4.3 to 10.8) 10.0 (7.4 to 12.6)
  12 months (n=49; 43; 36)† 6.0 (2.9 to 9.2) 7.3 (4.1 to 10.5) 8.3 (5.3 to 11.3)
Health-related quality of life (SF-36)—Physical Component Score
  6 weeks (n=80; 74; 69)† −6.7 (−9.4 to −4.0) −6.2 (−8.7 to −3.7) −6.8 (−9.4 to −4.2)
  3 months (n=69; 62; 60)† −7.8 (−10.2 to −5.4) −8.1 (−10.6 to −5.7) −8.6 (−11.2 to −6.0)
  6 months (n=57; 61; 58)† −9.1 (−11.6 to −6.7) −9.9 (−12.3 to −7.5) −10.2 (−12.9 to −7.5)
  9 months (n=60; 61; 58)† −7.5 (−10.0 to −5.0) −12.0 (−14.5 to −5.0) −11.2 (−13.7 to −8.6)
  12 months (n=59; 52; 46)† −9.9 (−12.2 to −7.6) −11.0 (−13.4 to −8.6) −11.6 (−14.1 to −9.1)
Health-related quality of life (SF-36)—Mental Component Score
  6 weeks (n=80; 74; 69)† −3.3 (−6.8 to −0.1) −2.1 (−5.7 to −1.5) −1.5 (−4.9 to −1.9)
  3 months (n=69; 62; 60)† −5.0 (−8.3 to −1.7) −6.8 (−10.0 to −3.6) −7.0 (−16.5 to −2.6)
  6 months (n=57; 61; 58)† −2.6 (−6.2 to −1.1) −5.6 (−9.1 to −2.2) −5.8 (−15.7 to −4.1)
  9 months (n=60; 38; 45)† −5.5 (−8.8 to −2.2) −7.8 (−11.1 to −4.5) −8.5 (−11.4 to −5.5)
  12 months (n=59; 52; 46)† −7.1 (−10.3 to −3.9) −7.4 (−10.6 to −4.1) −7.3 (−10.5 to −4.1)
*Sample sizes for government-regulated guideline, preferred-provider insurance-based rehabilitation and general practitioner education and 
activation, respectively.
†Using generalised estimating equation models, there was statistically significant improvement over time in all groups (p<0.0001). Clinically 
important differences were two points on Numeric Rating Scale, 21.4 points on Whiplash Disability Questionnaire, 7.7 points on the SF-36 
Physical Component Score and 10% for Centre for Epidemiological Studies Depression and SF-36 Mental Component Score.
SF-36,   36-item Short Form Survey.
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multimodal interventions include an average of six visits 
during the first 8 weeks of care.22 Future research exam-
ining potential dose-response relationships with treat-
ment visits under a government-regulated guideline 
scheme and recovery is warranted.
We did not confirm the results from cohort studies 
which suggested that low-intensity general practitioner-di-
rected care may be superior to other conservative 
management.6 7 17 19 Several reasons may help explain this 
finding. First, previous results were from Saskatchewan in 
the mid-1990s when management of whiplash injuries was 
not guided by a treatment protocol, such as the govern-
ment-regulated programme. A regulated management 
programme (especially when applied in a standardised 
manner from a randomised trial) may yield benefits over 
unguided usual care. Second, evidence-based knowledge 
translation strategies (since the mid-1990s in Canada) 
have mainly targeted rehabilitation practitioners (physio-
therapists and chiropractors) rather than general prac-
titioners.29 30 32 76 77 This may have led to changes in the 
Table 3 Between-group differences for secondary outcomes*
Outcome
Government-regulated guideline 
group minus preferred-provider 
rehabilitation group
Mean difference (95% CI)
Government-regulated 
guideline group minus general 
practitioner education and 
activation group
Mean difference (95% CI)
Preferred-provider 
rehabilitation group minus 
general practitioner 
education and activation 
group
Mean difference (95% CI)
Neck pain intensity
  6 weeks 0.5 (−0.3 to 1.3) 0.2 (−0.7 to 1.0) 0.6 (−0.2 to 1.5)
  3 months 0.5 (−0.3 to 1.4) 0.0 (−1.0 to 0.9) 0.5 (−0.4 to 1.4)
  6 months 0.2 (−0.7 to 1.2) −0.1 (−1.1 to 0.9) 0.1 (−0.8 to 1.1)
  9 months 0.2 (0.8 to 1.2) 0.2 (−0.9 to 1.2) 0.4 (−0.6 to 1.4)
  12 months 0.7 (−0.1 to 1.5) −0.3 (−1.2 to 0.6) 0.4 (−0.5 to 1.2)
Whiplash disability
  6 weeks 0.0 (−8.4 to 8.4) 0.2 (−9.2 to 9.5) 0.2 (− 8.7 to 9.0)
  3 months 3.0 (−6.2 to 12.2) −1.1 (−10.9 to 8.7) 1.9 (−7.5 to 11.2)
  6 months −5.5 (−15.9 to 4.9) −2.7 (−13.2 to 7.8) −8.2 (−18.7 to 2.2)
  9 months −1.8 (−13.2 to 9.6) 2.8 (−8.7 to 14.3) 1.0 (−10.1 to 12.0)
  12 months −4.8 (−15.2 to 5.6) 3.3 (−7.3 to 14.0) −1.5 (−12.3 to 9.3)
Depressive symptomatology
  6 weeks 1.7 (−1.8 to 5.2) −2.5 (−6.3 to 1.3) −0.8 (−4.4 to 2.8)
  3 months −0.7 (−4.8 to 3.4) −0.2 (−4.4 to 4.0) −0.9 (−5.1 to 3.3)
  6 months −1.5 (−5.7 to 2.6) −0.6 (−5.1 to 3.8) −2.2 (−7.0 to 2.7)
  9 months 0.6 (−3.8 to 5.0) −2.8 (−7.6 to 2.0) −2.2 (−6.6 to 2.2)
  12 months 0.9 (−4.1 to 5.8) −1.8 (−6.8 to 3.2) −0.9 (−5.7 to 3.9)
Health-related quality of life (SF-36)—Physical Component Score
  6 weeks 0.4 (−2.8 to 3.7) 0.2 (−3.2 to 3.5) 0.6 (−2.4 to 3.7)
  3 months 0.4 (−3.0 to 3.9) −0.2 (−3.9 to 3.5) 0.2 (−3.1 to 3.5)
  6 months 0.4 (−3.0 to 3.8) −1.0 (−5.0 to 2.9) −0.7 (−4.4 to 3.1)
  9 months 3.8 (−0.5 to 8.2) −2.9 (−7.4 to 1.6) 0.9 (−3.1 to 4.9)
  12 months 1.6 (−2.0 to 5.1) −2.1 (−6.1 to 2.0) −0.5 (−4.4 to 3.4)
Health-related quality of life (SF-36)—Mental Component Score
  6 weeks −3.3 (−7.4 to 0.9) −0.8 (−4.9 to 3.2) −4.1 (−8.4 to 0.3)
  3 months −0.7 (−5.4 to 4.0) −0.7 (−5.3 to 4.0) −1.3 (−6.2 to 3.6)
  6 months 2.2 (−2.7 to 7.1) 0.3 (−4.1 to 4.7) 2.6 (−2.5 to 7.6)
  9 months −0.3 (−6.1 to 5.5) 1.8 (−3.6 to 7.2) 1.5 (−4.1 to 7.1)
  12 months −1.5 (−6.7 to 3.8) −0.6 (−5.2 to 4.0) −2.1 (−7.2 to 3.0)
*Clinically important differences were two points on Numeric Rating Scale, 21.4 points on Whiplash Disability Questionnaire, 7.7 points on the 
SF-36 Physical Component Score and 10% for Centre for Epidemiological Studies Depression and SF-36 Mental Component Score.
SF-36,    36-item Short Form Survey. 
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clinical management of WAD by the former groups of 
clinicians. Third, automobile insurance rehabilitation 
practices in Ontario may have created a culture where 
injured persons with WAD expect rehabiltation; one or 
two visits to a general practitioner may not be perceived 
as a form of rehabilitation. Patients may expect to receive 
rehabilitation care and may not perceive general practi-
tioner-based activation and rehabilitation as sufficient. 
This may explain why more participants allocated to this 
group sought co-interventions. In contrast, the govern-
ment-regulated guideline group did not receive multidis-
ciplinary rehabilitation and sought fewer co-interventions 
outside of the study protocol. Finally, delivery of an educa-
tional intervention alone may be ineffective. Recent 
studies, as identified in a previous systematic review, 
reported that education interventions alone provide 
minimal or no benefit in the management of WAD.15
study strengths and limitations
Our study had several strengths. First, we recruited a 
consecutive sample of participants early after the injury 
from a single insurer (median 5–6 days). Second, vari-
ability in the delivery of multidisciplinary care was mini-
mised because treatment was provided at the same clinics 
in a geographic location, but by independent clinicians. 
Third, our trial was informed by a pilot study. A summary 
of the results of the pilot study are provided in the associ-
ated protocol paper.33 Finally, we used a valid and reliable 
patient-centred outcome that provides a global measure 
of recovery.
Our study had some limitations. First, it was not 
possible to blind participants to the received interven-
tion. Second, a higher proportion of participants allo-
cated to preferred-provider rehabilitation and to general 
practitioner education and activation care reported using 
healthcare services outside the study protocol. However, 
it is likely that a considerable proportion of these partic-
ipants received government-regulated rehabilitation 
outside of the study because this was the standard of care 
at the time of the study, which would reduce the contrast 
between groups. Moreover, fewer co-interventions in 
the government-regulated guideline group adds further 
weight that the government-regulated rehabilitation was 
more effective. Third, the follow-up rate was 65.3% at 
3 months, 61.8% at 6 months and 54.4% at 9 months for 
the primary outcome. However, the 12-month follow-up 
rate for the primary outcome was 78.8%. In addition, 
recovery was assessed at 3, 6, 9 and 12 months to calcu-
late time to recovery, whereas participants may have 
recovered earlier during the interval periods. Moreover, 
those who consulted a lawyer about their claim at base-
line or did not expect to get better/did not know about 
their recovery were more likely to drop out. However, 
we explored the confounding effect of expectation of 
recovery and consulting a lawyer, and these did not bias 
our analysis. Reasons reported for study withdrawal were: 
self-perceived lack of importance, dissatisfaction with 
care received and advised to withdraw by their lawyer. 
Finally, these results may not be generalisable to settings 
and other jurisdictions outside of Ontario.
COnClusIOn
The results of our trial suggest that a government-reg-
ulated guideline is not more effective than a physi-
cian-based education and activation or preferred-provider 
rehabilitation intervention in promoting global recovery 
of patients with acute WAD. Similarly, we found no differ-
ences in neck-specific outcomes, depression or quality 
of life between groups. However, the government-regu-
lated guideline may be associated with temporary faster 
self-rated recovery in the first 80 days postinjury, but this 
finding needs to be validated in future research.
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